Activity of an innate defence regulator peptide to alleviate airway inflammation is mitigated by disruption of its central hydrophobic region

H. Piyadasa (Winnipeg, Canada), M. Hemshekhar (Winnipeg, Canada), A. Altieri (Winnipeg, Canada), S. Basu (Winnipeg, Canada), A. Van Der Does (Leiden, Netherlands), A. Halayko (Winnipeg, Canada), P. Hiemstra (Leiden, Netherlands), N. Mookherjee (Winnipeg, Canada)

Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Piyadasa (Winnipeg, Canada), M. Hemshekhar (Winnipeg, Canada), A. Altieri (Winnipeg, Canada), S. Basu (Winnipeg, Canada), A. Van Der Does (Leiden, Netherlands), A. Halayko (Winnipeg, Canada), P. Hiemstra (Leiden, Netherlands), N. Mookherjee (Winnipeg, Canada). Activity of an innate defence regulator peptide to alleviate airway inflammation is mitigated by disruption of its central hydrophobic region. 1104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: